A novel Copper(II) complex based on mixed ligands, the phytochemical compound baicalein and ancillary ligand 1,10-phenanthroline, [Cu(baic)(phen)NO₃], was synthesized and characterized by UV–visible, FTIR, EPR, and mass spectrometry. The analysis of the geometry was further analyzed using DFT, yielding a narrow HOMO–LUMO gap (2.63 eV), reflecting enhanced reactivity. The complex was found to have copper in the +2-oxidation state and to be penta-coordinated. Studies of DNA and BSA interaction were carried out using UV and FL spectroscopic assays revealed satisfactory binding affinity to DNA, with statistical values of Kb = 1.26 × 104 M⁻1 and Ksv = 2.71 × 103 M 1, and to BSA, with Ksv = 1.15×105 M−1, respectively. EtBr quenching studies gave us insight into the partial intercalative mode of complexation, and to correlate the same, we performed molecular docking studies. It revealed that the experimentally observed DNA-binding affinity, with a binding constant of (1.26 ± 0.10) × 104 M⁻1, was complemented by molecular docking against the 2D55 DNA duplex, which produced a binding score of −6.9 kcal/mol and a mixed, partially intercalative binding orientation; redocking of the native ligand yielded an RMSD of 0.376 Å, supporting the reliability of the docking protocol. This agreement was extended over 100 ns MD simulations, which confirmed stable, low-RMSD/RMSF binding of the complex to both DNA (2D55) and riboflavin kinase (1QS9), a metastasis-associated enzyme, thereby providing a plausible molecular rationale for the anti-metastatic phenotype observed in the cell-based assays. The complex exhibited moderate selective cytotoxicity against A549 cells (IC₅₀ = 115 µg/ml [201 µM]) relative to L929 cells (IC₅₀ = 458.21 µg/ml [800 µM]), with a ~4-fold increase in apoptosis and dose-dependent caspase−3 activation. To understand the [Cu(baic)(phen)NO₃]’s anti-metastasis activity, wound healing assays were performed, and they demonstrated 38% suppression of cell motility at 48 h, whereas Transwell invasion assays confirmed >50% inhibition at the IC₅₀ concentration of the complex. The complex was found to be more effective as an anti-metastasis agent than as a cytotoxic agent.Taken together, the mutual reinforcement of spectroscopic, cellular, and computational evidence indicates that the complex behaves as a considerably more effective anti-metastatic than cytotoxic agent.


扫码关注我们
求助内容:
应助结果提醒方式:

